Multiple sclerosis. Part I: Neuro-ophthalmic manifestations
Authors:
- John H PulaJPJohn H Pula
- Anthony T RederARAnthony T Reder
- 1 November 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 20 (6) , 467-475
Abstract
This update includes topics relating to multiple sclerosis (MS) for the ophthalmologist. Interest in the ophthalmology of MS is highlighted by the substantial amount of original research presented at recent medical conferences. At the 2008 World Congress on Treatment and Research in Multiple Sclerosis, 33 of 898 abstract presentations related to ophthalmology. The most represented topics were optical coherence tomography (OCT) and radiology of the visual system (19/33 posters). The 2009 North American neuro-ophthalmologic society (NANOS) conference featured MS-related topics in 6 of 24 platform presentations. This article reviews recent advancements in the neuro-ophthalmology of MS. Multiple sclerosis results in various ophthalmic abnormalities. Optic neuritis is the most widely studied visual disturbance in MS, but other unusual visual manifestations such as Charles Bonnet syndrome or the Pulfrich phenomenon also occur. OCT is used to measure thickness of the retinal nerve fiber layer. Because thinning of this layer in MS represents axonal loss, OCT is being used to evaluate neuroprotective treatments. The efferent visual system, in particular the medial longitudinal fasciculus pathway, may be a way to measure body temperature-induced changes in MS.Keywords
This publication has 44 references indexed in Scilit:
- Early MRI in optic neuritisNeurology, 2009
- Idiopathic Chiasmal NeuritisArchives of Ophthalmology (1950), 2009
- Management of optic neuritis and impact of clinical trials: An international surveyJournal of the Neurological Sciences, 2009
- Optic neuritis and the risk of multiple sclerosis--what can we learn from a brain MRI scan?Nature Clinical Practice Neurology, 2008
- Association of Gadolinium Based Magnetic Resonance Imaging Contrast Agents and Nephrogenic Systemic FibrosisJournal of Urology, 2008
- Visual Function 15 Years after Optic NeuritisOphthalmology, 2008
- Optic Nerve Degeneration in Experimental Autoimmune EncephalomyelitisOphthalmic Research, 2008
- SIRT1 Activation Confers Neuroprotection in Experimental Optic NeuritisInvestigative Ophthalmology & Visual Science, 2007
- Ocular manifestations of multiple sclerosisCurrent Opinion in Ophthalmology, 2005
- Neuro-ophthalmology of multiple sclerosisCurrent Opinion in Ophthalmology, 1996